Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TASTER: Ticagrelor ODT vs Standard Tablet in MI
NCT03822377Phase 3Completed
- Sponsor
- AOU Sassari
- Start
- Jun 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ticagrelor in ST elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI), sponsored by AOU Sassari. Started Jun 2019; status: completed.
02
Drugs
ticagrelor
03
Conditions
ST elevation myocardial infarction (STEMI)non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT03822377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03822377.